Northern Trust’s AIM ImmunoTech AIM Stock Holding History

Northern Trust’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-852	Closed	-$10.4K	–	4551
2025 Q1	$10.4K	Hold	852	–	–	﹤0.01%	4384
2024 Q4	$16.9K	Hold	852	–	–	﹤0.01%	4390
2024 Q3	$23K	Hold	852	–	–	﹤0.01%	4321
2024 Q2	$31.7K	Sell	852 -1	-0.1%	-$42	﹤0.01%	4279
2024 Q1	$40.1K	Sell	853 -4	-0.5%	-$166	﹤0.01%	4257
2023 Q4	$37.6K	Hold	857	–	–	﹤0.01%	4279
2023 Q3	$38.9K	Sell	857 -9	-1%	-$555	﹤0.01%	4224
2023 Q2	$58K	Hold	866	–	–	﹤0.01%	4183
2023 Q1	$37.2K	Hold	866	–	–	﹤0.01%	4325
2022 Q4	$27K	Hold	866	–	–	﹤0.01%	4421
2022 Q3	$50K	Sell	866 -22	-2%	-$1.54K	﹤0.01%	4324
2022 Q2	$69K	Hold	888	–	–	﹤0.01%	4309
2022 Q1	$94K	Hold	888	–	–	﹤0.01%	4365
2021 Q4	$82K	Buy	888 +3	+0.3%	+$464	﹤0.01%	4479
2021 Q3	$179K	Buy	885 +12	+1%	+$2.42K	﹤0.01%	4227
2021 Q2	$188K	Buy	873 +195	+29%	+$41.8K	﹤0.01%	4181
2021 Q1	$154K	Buy	678 +34	+5%	+$7.68K	﹤0.01%	4179
2020 Q4	$115K	Sell	644 -9	-1%	-$1.8K	﹤0.01%	4088
2020 Q3	$140K	Buy	653 +77	+13%	+$19.2K	﹤0.01%	3888
2020 Q2	$143K	Buy	+576	New	+$140K	﹤0.01%	3839
2019 Q2	–	Sell	-7	Closed	-$5K	–	4362
2019 Q1	$5K	Hold	7	–	–	﹤0.01%	4200
2018 Q4	$5K	Hold	7	–	–	﹤0.01%	4241
2018 Q3	$7K	Hold	7	–	–	﹤0.01%	4273
2018 Q2	$11K	Hold	7	–	–	﹤0.01%	4249
2018 Q1	$13K	Hold	7	–	–	﹤0.01%	4194
2017 Q4	$11K	Hold	7	–	–	﹤0.01%	4191
2017 Q3	$11K	Hold	7	–	–	﹤0.01%	4200
2017 Q2	$16K	Hold	7	–	–	﹤0.01%	4199
2017 Q1	$17K	Buy	7 +3	+75%	+$7.67K	﹤0.01%	4171
2016 Q4	$11K	Hold	4	–	–	﹤0.01%	4130
2016 Q3	$21K	Hold	4	–	–	﹤0.01%	4102
2016 Q2	$24K	Hold	4	–	–	﹤0.01%	4104
2016 Q1	$27K	Hold	4	–	–	﹤0.01%	4104
2015 Q4	$17K	Hold	4	–	–	﹤0.01%	4185
2015 Q3	$35K	Hold	4	–	–	﹤0.01%	4137
2015 Q2	$42K	Hold	4	–	–	﹤0.01%	4087
2015 Q1	$53K	Hold	4	–	–	﹤0.01%	4144
2014 Q4	$59K	Hold	4	–	–	﹤0.01%	4075
2014 Q3	$76K	Hold	4	–	–	﹤0.01%	4078
2014 Q2	$74K	Sell	4 -1	-20%	-$17.9K	﹤0.01%	4062
2014 Q1	$97K	Hold	5	–	–	﹤0.01%	3947
2013 Q4	$65K	Hold	5	–	–	﹤0.01%	3945
2013 Q3	$57K	Hold	5	–	–	﹤0.01%	3923
2013 Q2	$54K	Buy	+5	New	+$59.6K	﹤0.01%	3921

Other funds holding AIM

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Northern Trust's AIM Position: Q2 2025 in Review

Northern Trust sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 852 shares — an estimated $10.4K sold.

Northern Trust first reported a position in AIM in Q2 2013 and held it in 44 quarters. The position peaked at $188K in Q2 2021. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

Northern Trust reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
Northern Trust sold 852 AIM ImmunoTech shares in Q2 2025, an estimated $10.4K.
Northern Trust first reported a position in AIM ImmunoTech in Q2 2013 and held it in 44 quarters.
Northern Trust's AIM ImmunoTech position peaked at $188K in Q2 2021.
12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.